Synagis Prior Authorization Criteria - Alabama

Notification Icon This version of the form is not currently in use and is provided for reference only. Download this version of the document for the current year.

Synagis Prior Authorization Criteria - Alabama

Synagis Prior Authorization Criteria is a legal document that was released by the Alabama Medicaid Agency - a government authority operating within Alabama.

FAQ

Q: What is Synagis?
A: Synagis is a medication that helps prevent serious respiratory syncytial virus (RSV) infections in high-risk infants.

Q: What is respiratory syncytial virus (RSV)?
A: Respiratory syncytial virus (RSV) is a common virus that can cause serious lung infections in infants and young children.

Q: Who is considered high-risk for RSV infection?
A: Infants and young children who were born prematurely (before 29 weeks of gestation) or have certain heart or lung conditions are considered high-risk for RSV infection.

Q: What is Synagis prior authorization criteria?
A: Synagis prior authorization criteria refers to the specific requirements that need to be met for insurance coverage of the medication.

ADVERTISEMENT

Form Details:

  • Released on October 1, 2021;
  • The latest edition currently provided by the Alabama Medicaid Agency;
  • Ready to use and print;
  • Easy to customize;
  • Compatible with most PDF-viewing applications;

Download a printable version of the form by clicking the link below or browse more documents and templates provided by the Alabama Medicaid Agency.

Download Synagis Prior Authorization Criteria - Alabama

4.3 of 5 (14 votes)
  • Synagis Prior Authorization Criteria - Alabama, Page 1
ADVERTISEMENT